PINK1 and Parkinson disease: We also observed that the inflammatory genes downregulated in the glial cultures treated with the SGK1 inhibitor included components of the cyclic GMP‐AMP synthase (CGAS)‐stimulator of interferon response cGAMP interactor 1 genes (STING) pathway (Fig 3E and F), which has recently been identified as another critical pathogenic contributor to PD caused by Parkin and PINK1 mutations (Sliter et al, 2018).